Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Tennessee for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Tennessee only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Tennessee (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Dana Thompson (NPI 1306862669)

Field	Value
Entity Type	Individual
Organization	Dana Thompson
Address	250 25th Ave N
City	Nashville
State	TN
ZIP	37203
Taxonomy	Medical Oncology Physician
NPI Enumerated	July 13, 2006

Payer Source	Total Paid
Medicare	$2.2M
Medicaid	$0

Key Findings

Provider profile and tenure: DANA THOMPSON is a Medical Oncology Physician enumerated nearly 20 years ago (NPI registered 2006-07-13), indicating long-standing participation in Medicare billing and sustained clinical activity in oncology-focused services over an extended period. The longevity supports experience managing infusion-based cancer therapies and related office-based oncology care.

Medicare-centered payer mix: This provider’s billings are effectively single-payer in the available data — lifetime Medicare revenue is $2.2M while there is no Medicaid billing on file. That gap indicates the provider operates primarily within the Medicare market or does not submit claims to state Medicaid programs.

Revenue concentration in Medicare: The top three Medicare codes by revenue account for 72.6% of this provider’s total Medicare revenue, showing a high concentration of income in a few drug administrations. This concentration suggests the practice’s revenue stream is heavily dependent on high-cost oncology drug administration rather than a broad mix of lower-cost E/M or ancillary services.

Service-line implications from top codes: The largest revenue driver is J9271 (pembrolizumab), followed by J9299 (nivolumab) and J0897 (denosumab), which together dominate the revenue mix. These drugs are checkpoint inhibitors and bone-modifying agents commonly used in medical oncology, indicating the practice focuses on infusion-based immunotherapy and supportive oncology care rather than, for example, radiation or surgical oncology.

Competitive standing on key drugs: For J9271 the provider ranks #308 of 1841 (83rd percentile), which places them as a solid, above-average national participant for pembrolizumab administration but not a top national outlier. For J9299 the ranking is #221 of 505 (56th percentile), indicating unremarkable, mid-level participation among providers who bill that code. For J0897 the provider ranks #894 of 10057 (91st percentile), showing relatively high national activity for denosumab compared with peers.

Notable high-volume exceptions: Several non-drug service codes show unusually high national percentiles. J0881 (darbepoetin alfa) ranks in the 95th percentile (#61 of 1114) and 99214 ranks in the 95th percentile (#21718 of 479517), both labeled as “notably above typical national volume.” These elevated percentiles suggest the provider performs above-typical volumes for certain anemia-management injections and mid-level office E/M visits, consistent with ongoing management of complex oncology patients.

Clinic operations and infusion workload: High claim counts for administration and infusion codes — for example 96413 (508 claims) and multiple additional infusion add-on codes (96367, 96417) — alongside large claim volumes for injectable oncology drugs suggest a practice model centered on regular in-office infusions and serial administrations. The mix of chemotherapy administration, infusion continuation, and immunotherapy products points to a clinic workflow organized around recurring infusion sessions.

Ancillary services and lab activity: The provider reports high-volume lab and specimen-related codes (80053, 85025, 36415, 82784) with national percentiles often in the upper quartile or higher (many in the 80s–99th percentiles), indicating that routine lab monitoring and blood draws are a consistent adjunct to treatment. This pattern is typical for oncology practices that perform on-site monitoring to support infusions and manage treatment toxicity.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

84 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	22,000	$40	$946K
J9299	Injection, nivolumab, 1 mg	16,120	$20	$386.9K
J0897	Injection, denosumab, 1 mg	11,520	$20	$207.4K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	52,100	$1	$104.2K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	760	$90	$65.7K
J1439	Injection, ferric carboxymaltose, 1 mg	64,500	$1	$64.5K
J1454	Injection, fosnetupitant 235 mg and palonosetron 0.25 mg	140	$340	$48.5K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	510	$90	$45.7K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	320	$130	$40.4K
J2506	Injection, pegfilgrastim, excludes biosimilar, 0.5 mg	440	$90	$40.4K

Showing 1–10 of 84

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 84 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Tennessee Distribution

Dana Thompson — 6 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Tennessee

Full comparison — all codes billed, vs. state median

84 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	12	50	17,400	$40	$776.1K
J9299	12	20	21,010	$20	$487.5K
J0897	18	240	2,940	$20	$85K
J0881	6	70	19,050	$1	$54.4K
J2506	20	40	430	$80	$46.7K
J1439	20	90	34,130	$1	$38.6K
J1454	6	70	70	$340	$25.6K
J9217	85	110	130	$130	$22K
96413	24	240	150	$90	$18.9K
99214	483	11,370	120	$80	$16.6K

Showing 1–10 of 84

Related Providers

Other providers that share a Tax Identification Number (TIN) with Dana Thompson, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Tennessee Oncology PLLC	TN	Hematology & Oncology Physician	$0	$8.5M
James Gray	TN	Radiation Oncology Physician	$4.9M	$0
Mark Womack	TN	Hematology & Oncology Physician	$2.4M	$0
Bertrand Anz	TN	Hematology & Oncology Physician	$2.4M	$0
Kent Shih	TN	Hematology & Oncology Physician	$2.2M	$0
Joshua Mondschein	TN	Radiation Oncology Physician	$2.1M	$0
Derek Holland	TN	Hematology & Oncology Physician	$2M	$0
Josiah Magnusson	FL	Nuclear Medicine Physician	$1.8M	$0
William Donnellan	TN	Hematology & Oncology Physician	$1.7M	$0
Clint Kingsley	AL	Hematology & Oncology Physician	$1.6M	$22K

Nearby Providers

Other providers in the same ZIP code as Dana Thompson, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Hca Health Services Of Tennessee, Inc.	TN	General Acute Care Hospital	$0	$45.9M
Pediatrix Medical Group Of Tennessee, P.C.	TN	Neonatal-Perinatal Medicine Physician	$0	$32.3M
Saint Thomas Medical Partners	TN	Internal Medicine Physician	$0	$21.9M
Radiology Alliance PC	TN	Diagnostic Radiology Physician	$0	$13.2M
Emergency Medicine Services Of Tn, PC	TN	Emergency Medicine Physician	$0	$12.9M
Tennessee Maternal-fetal Medicine LLC	TN	Specialist	$0	$12.5M
The Next Door, Inc.	TN	Substance Abuse Rehabilitation Facility	$0	$8.6M
Vcphcs Ix, LLC	TN	Substance Use Disorder Rehabilitation Clinic/Center	$257.7K	$6.6M
Tennessee Retina PC	TN	Retina Specialist (Ophthalmology) Physician	$0	$6M
Pediatric Associates Of Davidson County, P.C.	TN	Pediatrics Physician	$0	$5.8M

Dana Thompson — Billing Profile & Reimbursement Data

Sign up for Dana Thompson — Billing Profile & Reimbursement Data policy alerts

Dana Thompson — Billing Profile & Reimbursement Data

Sign up for Dana Thompson — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References